[1] Vaupel P, Kellehe DK, Thews O. Modulation of tumor oxygenatio.Int J Radiat Oncol Biol Phys,1998,42(4):843-848.
[2] Lee CG, Heijn M, di Tomaso E. Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. Cancer Res, 2000, 60(19):5565-5570.
[3] Ansiaux R, Baudelet C, Jordan BF. Thalidomide radiosensitizes tumors through early changes in the tumor microenvironment. Clin Cancer Res, 2005, 11(2 Pt 1):743-750.
[4] 张红梅,王唯红.乙丙昔罗对肿瘤放射治疗的增敏作用及机制.中国新药与临床杂志,2004,23(11):799-803.
[5] Nguyen LN, Munshi A, Hobbs ML, et al. Paclitaxel restores radiation-induced apoptosis in a bcl-2-expressing, radiation resistant lymphoma cell line. Int J Radiat Oncol Biol Phys, 2001,49(4):1127-1132.
[6]
[7] 袁健,孙宁.细胞周期与鼻咽癌的放射增敏.海南医学院学报,2004,10(3):139-142.
[8] Kuhne M, Riballo E, Rief N, et al. Double-strand break repair defect in ATM-deficient cells contributes to radiosensitivity.Cancer Res, 2004, 64(2):500-508.
[9] Allal AS, Kahne T, Reverdin AK, et al. Radioresistance-related proteins in rectal cancer. Proteomics, 2004, 4(8):2261-2269.
[10] Kim CH, Park SJ, Lee SH. A targeted inhibition of DNA-dependent protein kinase sensitizes breast cancer cells following ionizing radiation. J Pharmacol Exp Ther, 2002, 303(2):753-759.
[11] Dikomey E, Duen D. Effect of heat on DSB repair in G1- and Sphase studied in the human HeLa S3 cell line. Int J Radiat Biol,2000, 76(10):1335-1341.
[12] Seno JD, Dynlacht JR. Intracellular redistribution and modification of proteins of the Mre11/Rad50/Nbs1 DNA repair complex following irradiation and heat-shock. J Cell Physiol, 2004, 199(2):157-170.
[13] Nikiforova MN, Stringer JR, Blough R, et al. Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells. Science, 2000, 290(5489):138-141.
[14] Gradzka I, Buraczewska I, Kuduk-Jaworska J, et al. Radiosensitizing properties of novel hydroxydicarboxylatoplatinum (Ⅱ) complexes with high or low reactivity with thiols:two modes of action. Chem Biol Interact, 2003, 146(2):165-177.
[15] Wachters FM, van Putten JW, Maring JG, et al. Selective targeting of homologous DNA recombination repair by gemcitabine. Int J Radiat Oncol Biol Phys, 2003, 57(2):553-562.
[16] Dittmann K, Mayer C, Rodemann HP. Inhibition of radiation-induced EGFR nuclear import by C225(Cetuximab) suppresses DNA-PK activity. Radiother Oncol, 2005, 76(2):157-161.
[17] Tavema P, Hwang HS, Schupp JE, et al. Inhibition of base excision repair potentiates iododeoxyuridine-induced cytotoxicity and radiosensitizer. Cancer Res, 2003, 63(4):838-846.
[18]
[19] 崔滨滨,刘明,赵鹏,等.重组腺病毒介导的野生型p53基因对结直肠癌细胞的放射治疗增敏作用.中华外科杂志,2005,43(15):1002-1005.
[20] Gallo O, Boddi V, Calzolari A, et al. Bcl-2 protein expression correlates with recurrence and survival in early stage head and neck cancer treated by radiotherapy. Clin Cancer Res, 1996, 2(2):261-267.
[21] Kelly JD, Williamson KE, Weir HP, et al. Induction of apoptosis by mitomycin-C in an exvivo model of bladder cancer. BJU Int,2000, 85(7):911-917.
[22] Rischin D, Peters L, Hicks R, et al. Phase I trial of concurrent tirapazamine, cisplatin, and radiotherapy in patients with advanced head and neck cancer. J Clin Oncol, 2001, 19(2):535-542.